May 22, 2025
Boehringer Ingelheim Showcases Bold Vision for the Future of Cancer Care at ASCO 2025
Feb 19, 2025
Boehringer's zongertinib receives Priority Review from U.S. FDA for the treatment of HER2 (ERBB2)-mutant advanced non-small cell lung cancer
Aug 22, 2024
Boehringer Ingelheim Celebrates International Dog Day with Major Donations and Volunteer Work in Metro Atlanta with Local Animal Welfare Organizations
Jun 12, 2024
Boehringer Ingelheim CARES Foundation Ignites a Brighter Future in Vet Med with a $500,000 Scholarship Pledge to Tuskegee University College of Veterinary Medicine
May 03, 2024
Boehringer Ingelheim Unveils New R&D Laboratory in St. Joseph, Mo., Pioneering the Future of Animal Health Products
Mar 15, 2024
1.9 Million Doses of NexGard® PLUS (afoxolaner, moxidectin and pyrantel chewable tablets): Donated by Boehringer Ingelheim Cares Foundation to Aid Shelter Dogs in Need
Jan 04, 2024
Boehringer Ingelheim and 3T Biosciences enter into a second partnership to develop next-generation cancer immunotherapies
Jan 18, 2021
Cure Genetics Collaborates with Boehringer Ingelheim to Develop Novel AAV Vectors Enabling the Next-generation Liver-targeted Gene Therapy
Nov 30, 2020
Queen Latifah and Bernie Williams star in "Beyond Breathless" documentary on A&E
Oct 23, 2020
New Jardiance® findings showed improved cardio-renal outcomes in adults with heart failure with reduced ejection fraction regardless of chronic kidney disease status
Sep 17, 2020
Boehringer Ingelheim And Mirati Therapeutics Announce Clinical Collaboration To Study BI 1701963, A SOS1::pan-KRAS Inhibitor In Combination With MRTX849, A KRAS G12C Selective Inhibitor
Jun 19, 2020
Full results from EMPERIAL exercise ability trials presented
Jun 16, 2020
$274.6 Billion Worldwide Immunotherapy Drugs Industry to 2025 - Featuring Abbvie, Amgen & Boehringer Ingelheim Among Others
May 26, 2020
Boehringer Ingelheim and Lilly to collaborate with Duke Clinical Research Institute on a pragmatic trial examining Jardiance's® effects following an acute myocardial infarction
May 26, 2020
German Respiratory Devices Market, Forecast to 2025 - Focus on Therapeutic Devices, Diagnostic & Monitoring Devices, Consumables & Accessories
May 25, 2020
OFEV® (nintedanib) now available in Canada for adults living with progressive fibrosing interstitial lung diseases (PF-ILD)(1)
May 18, 2020
Boehringer Ingelheim expands free telemedicine platform to connect veterinarians and pet owners at a time of social distancing
May 14, 2020
Veterinary Vaccines Market Worth $11.3 Billion by 2025 - Exclusive Report by MarketsandMarkets(TM)
May 12, 2020
Pope McGlamry P.C. Announces Plaintiffs' Leadership Role in the Zantac/Ranitidine Products Liability Litigation
May 06, 2020
BERG Forms Research Collaboration With Boehringer Ingelheim To Identify Candidate Biomarkers For A Group Of Inflammatory Conditions